<SEC-DOCUMENT>0000950127-22-000003.txt : 20220112
<SEC-HEADER>0000950127-22-000003.hdr.sgml : 20220112
<ACCEPTANCE-DATETIME>20220112163047
ACCESSION NUMBER:		0000950127-22-000003
CONFORMED SUBMISSION TYPE:	SC 13D
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20220112
DATE AS OF CHANGE:		20220112

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ICU MEDICAL INC/DE
		CENTRAL INDEX KEY:			0000883984
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				330022692
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-44397
		FILM NUMBER:		22526904

	BUSINESS ADDRESS:	
		STREET 1:		951 CALLE AMANECER
		CITY:			SAN CLEMENTE
		STATE:			CA
		ZIP:			92763-6212
		BUSINESS PHONE:		949-366-2183

	MAIL ADDRESS:	
		STREET 1:		951 CALLE AMANECER
		CITY:			SAN CLEMENTE
		STATE:			CA
		ZIP:			92763-6212

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Smiths Group International Holdings Ltd
		CENTRAL INDEX KEY:			0001901425
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			0731

	FILING VALUES:
		FORM TYPE:		SC 13D

	BUSINESS ADDRESS:	
		STREET 1:		C/O SMITHS GROUP PLC
		STREET 2:		11-12 ST. JAMES'S SQUARE, 4TH FLOOR
		CITY:			LONDON
		STATE:			X0
		ZIP:			SW1Y 4LB
		BUSINESS PHONE:		4402070041600

	MAIL ADDRESS:	
		STREET 1:		C/O SMITHS GROUP PLC
		STREET 2:		11-12 ST. JAMES'S SQUARE, 4TH FLOOR
		CITY:			LONDON
		STATE:			X0
		ZIP:			SW1Y 4LB
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D
<SEQUENCE>1
<FILENAME>schedule-13d.htm
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: White & Case
         Document created using EDGARfilings PROfile 8.0.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div style="text-align: center; margin-bottom: 9pt; font-weight: bold;"><font style="font-size: 14pt;">SECURITIES AND EXCHANGE COMMISSION</font><br>
    Washington, D.C. 20549<br>
    <font style="font-size: 14pt;">SCHEDULE 13D</font><br>
    Under the Securities Exchange Act of 1934<br>
    (Amendment No.)*<br>
    <font style="font-size: 14pt;">ICU MEDICAL, INC.</font><br>
    (Name of Issuer)<br>
    Common Stock, par value $0.10 per share<br>
    (Title of Class of Securities)<br>
    44930G107<br>
    (CUSIP Number)</div>
  <div style="text-align: center; margin-bottom: 6pt; font-weight: bold;">Matthew Whyte<br>
    Company Secretary<br>
    Smiths Group plc<br>
    4<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor, 11-12 St James&#8217;s Square<br>
    London, England, SW1Y 4LB<br>
    +44 (0) 20 7004 1600</div>
  <div style="text-align: center; font-weight: bold;">(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)</div>
  <div style="text-align: center; margin-bottom: 9pt; font-style: italic; font-weight: bold;">with a copy to:</div>
  <div style="text-align: center; margin-bottom: 6pt; font-weight: bold;">Gregory Pryor<br>
    Patti J. Marks<br>
    White &amp; Case LLP<br>
    1221 Avenue of the Americas<br>
    New York, NY 10020-1095</div>
  <div style="text-align: center; margin-bottom: 6pt; font-weight: bold;">January 6, 2022<br>
    (Date of Event Which Requires Filing of this Statement)</div>
  <div style="text-align: justify; margin-bottom: 9pt;">If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this <font style="font-weight: bold;">Schedule 13D</font>, and is filing this
    schedule because of &#167;&#167;240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.&#160; &#9744;</div>
  <div style="text-align: justify; margin-bottom: 9pt;"><font style="font-weight: bold;">Note</font>: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.&#160; See &#167;240.13d-7 for other parties
    to whom copies are to be sent.</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z0b702e7af83c40baafd2200c202e3758">

      <tr>
        <td style="width: 4.81%; vertical-align: top;">
          <div style="text-align: justify;">*</div>
        </td>
        <td style="width: 95.19%; vertical-align: top;">
          <div style="text-align: justify;">The remainder of this cover page shall be filled out for a reporting person&#8217;s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information
            which would alter disclosures provided in a prior cover page.</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-top: 9pt; margin-bottom: 9pt;">The information required on the remainder of this cover page shall not be deemed to be &#8220;filed&#8221; for the purpose of Section 18 of the Securities Exchange Act of 1934 (&#8220;Act&#8221;) or
    otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).</div>
  <div style="text-align: justify; margin-bottom: 9pt;">CUSIP No. 44930G107</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div style="page-break-after: always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zfa4fe376cf6248db86c88be96745fe93">

      <tr>
        <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 5%;">
          <div style="text-align: justify;">1</div>
        </td>
        <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 92.39%; padding: 0px 0px 0px 5px;">
          <div>NAMES OF REPORTING PERSON<br>
            Smiths Group plc</div>
        </td>
      </tr>
      <tr>
        <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 5%;">
          <div style="text-align: justify;">2</div>
        </td>
        <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 92.39%; padding: 0px 0px 0px 5px;">
          <div>CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP<br>
            (a)&#160; &#9744;&#160; (b)&#160; &#9744;</div>
        </td>
      </tr>
      <tr>
        <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 5%;">
          <div style="text-align: justify;">3</div>
        </td>
        <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 92.39%; padding: 0px 0px 0px 5px;">
          <div>SEC USE ONLY</div>
        </td>
      </tr>

  </table>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zfa554285de0a44b6a584a1e649770841">

      <tr>
        <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 5%;">
          <div style="text-align: justify;">4</div>
        </td>
        <td colspan="3" style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 92.4%; padding: 0px 0px 0px 5px;">
          <div>SOURCE OF FUNDS (See Instructions)<br>
            00</div>
        </td>
      </tr>
      <tr>
        <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 5%;">
          <div style="text-align: justify;">5</div>
        </td>
        <td colspan="3" style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 92.4%; padding: 0px 0px 0px 5px;">
          <div>CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)<br>
            &#9744;<br>
          </div>
        </td>
      </tr>
      <tr>
        <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 5%;">
          <div style="text-align: justify;">6</div>
        </td>
        <td colspan="3" style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 92.4%; padding: 0px 0px 0px 5px;">
          <div>CITIZENSHIP OR PLACE OF ORGANIZATION<br>
            England and Wales</div>
        </td>
      </tr>
      <tr>
        <td style="vertical-align: top; width: 5%;">&#160;</td>
        <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 24.43%;">
          <div style="text-align: center;">NUMBER OF<br>
            SHARES</div>
        </td>
        <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 7.25%; text-align: center;">
          <div>7</div>
        </td>
        <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 60.72%; padding: 0px 0px 0px 5px;">
          <div>SOLE VOTING POWER<br>
            0</div>
        </td>
      </tr>
      <tr>
        <td style="vertical-align: top; width: 5%;">&#160;</td>
        <td style="border-bottom: 0px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 24.43%;">
          <div style="text-align: center;">BENEFICIALLY<br>
            OWNED BY</div>
        </td>
        <td style="border-bottom: 0px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 7.25%; text-align: center;">
          <div>8</div>
        </td>
        <td style="border-bottom: 0px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 60.72%; padding: 0px 0px 0px 5px;">
          <div>SHARED VOTING POWER<br>
            2,500,000 (1)</div>
        </td>
      </tr>
      <tr>
        <td style="vertical-align: top; width: 5%;">&#160;</td>
        <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 24.43%;">
          <div style="text-align: center;">EACH<br>
            REPORTING</div>
        </td>
        <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 7.25%; text-align: center;">
          <div>9</div>
        </td>
        <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 60.72%; padding: 0px 0px 0px 5px;">
          <div>SOLE DISPOSITIVE POWER<br>
            0</div>
        </td>
      </tr>
      <tr>
        <td style="vertical-align: top; width: 5%;">&#160;</td>
        <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 24.43%;">
          <div style="text-align: center;">PERSON<br>
            WITH</div>
        </td>
        <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 7.25%; text-align: center;">
          <div>10</div>
        </td>
        <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 60.72%; padding: 0px 0px 0px 5px;">
          <div>SHARED DISPOSITIVE POWER<br>
            2,500,000 (1)</div>
        </td>
      </tr>
      <tr>
        <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 5%;">
          <div style="text-align: justify;">11</div>
        </td>
        <td colspan="3" style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 92.4%; padding: 0px 0px 0px 5px;">
          <div>AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>
            2,500,000 (1)</div>
        </td>
      </tr>
      <tr>
        <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 5%;">
          <div style="text-align: justify;">12</div>
        </td>
        <td colspan="3" style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 92.4%; padding: 0px 0px 0px 5px;">
          <div>CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)<br>
            &#9744;<br>
          </div>
        </td>
      </tr>
      <tr>
        <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 5%;">
          <div style="text-align: justify;">13</div>
        </td>
        <td colspan="3" style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 92.4%; padding: 0px 0px 0px 5px;">
          <div>PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)<br>
            10.5% (2)</div>
        </td>
      </tr>
      <tr>
        <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 5%;">
          <div style="text-align: justify;">14</div>
        </td>
        <td colspan="3" style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 92.4%; padding: 0px 0px 0px 5px;">
          <div>TYPE OF REPORTING PERSON (See Instructions)<br>
            OO</div>
        </td>
      </tr>

  </table>
  <div style="margin-bottom: 9pt;"><br>
  </div>
  <div style="margin-bottom: 9pt;"><br>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div style="page-break-after: always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="margin-bottom: 9pt;">
    <table cellspacing="0" cellpadding="0" id="zfb148234bd1a4a9e9287f94f19989d03" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="border-bottom: 0px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 4.8%;">
            <div style="text-align: center;">1</div>
          </td>
          <td style="border-bottom: 0px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 95.2%; padding: 0px 0px 0px 5px;">
            <div>NAMES OF REPORTING PERSON<br>
              Smiths Group International Holdings Limited</div>
          </td>
        </tr>
        <tr>
          <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 4.8%;">
            <div style="text-align: center;">2</div>
          </td>
          <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 95.2%; padding: 0px 0px 0px 5px;">
            <div>CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP<br>
              (a) &#9744; (b) &#9744;&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="border-bottom: 0px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 4.8%;">
            <div style="text-align: center;">3</div>
          </td>
          <td style="border-bottom: 0px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 95.2%; padding: 0px 0px 0px 5px;">
            <div>SEC USE ONLY</div>
          </td>
        </tr>
        <tr>
          <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 4.8%;">
            <div style="text-align: center;">4</div>
          </td>
          <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 95.2%; padding: 0px 0px 0px 5px;">
            <div>SOURCE OF FUNDS (See Instructions)<br>
              00</div>
          </td>
        </tr>
        <tr>
          <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 4.8%;">
            <div style="text-align: center;">5</div>
          </td>
          <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 95.2%; padding: 0px 0px 0px 5px;">
            <div>CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)<br>
              &#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 4.8%;">
            <div style="text-align: center;">6</div>
          </td>
          <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 95.2%; padding: 0px 0px 0px 5px;">
            <div>CITIZENSHIP OR PLACE OF ORGANIZATION<br>
              England and Wales</div>
          </td>
        </tr>

    </table>
  </div>
  <div style="margin-bottom: 9pt;">
    <table cellspacing="0" cellpadding="0" id="z520b0ca1c7674dcb8edb556dd014253e" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid; vertical-align: top; width: 32.47%;">
            <div style="text-align: center;">NUMBER OF</div>
          </td>
          <td style="border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid; vertical-align: top; width: 8.28%;">
            <div style="text-align: center;">7</div>
          </td>
          <td style="border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid; vertical-align: top; width: 59.25%; padding: 0px 0px 0px 5px;">
            <div>SOLE VOTING POWER</div>
          </td>
        </tr>
        <tr>
          <td style="border-bottom: 1px solid; border-left: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; width: 32.47%;">
            <div style="text-align: center;">SHARES</div>
          </td>
          <td style="border-bottom: 1px solid; border-left: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; width: 8.28%;">&#160;</td>
          <td style="border-bottom: 1px solid; border-left: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; width: 59.25%; padding: 0px 0px 0px 5px;">
            <div>0</div>
          </td>
        </tr>
        <tr>
          <td style="border-left: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; width: 32.47%;">
            <div style="text-align: center;">BENEFICIALLY</div>
          </td>
          <td style="border-left: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; width: 8.28%;">
            <div style="text-align: center;">8</div>
          </td>
          <td style="border-left: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; width: 59.25%; padding: 0px 0px 0px 5px;">
            <div>SHARED VOTING POWER</div>
          </td>
        </tr>
        <tr>
          <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; width: 32.47%;">
            <div style="text-align: center;">OWNED BY</div>
          </td>
          <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; width: 8.28%;">&#160;</td>
          <td style="border-bottom: 1px solid; border-left: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; width: 59.25%; padding: 0px 0px 0px 5px;">
            <div>2,500,000 (1)</div>
          </td>
        </tr>
        <tr>
          <td style="border-left: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; width: 32.47%;">
            <div style="text-align: center;">EACH</div>
          </td>
          <td style="border-left: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; width: 8.28%;">
            <div style="text-align: center;">9</div>
          </td>
          <td style="border-left: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; width: 59.25%; padding: 0px 0px 0px 5px;">
            <div>SOLE DISPOSITIVE POWER</div>
          </td>
        </tr>
        <tr>
          <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; width: 32.47%;">
            <div style="text-align: center;">REPORTING</div>
          </td>
          <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; width: 8.28%;">&#160;</td>
          <td style="border-bottom: 1px solid; border-left: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; width: 59.25%; padding: 0px 0px 0px 5px;">
            <div>0</div>
          </td>
        </tr>
        <tr>
          <td style="border-left: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; width: 32.47%;">
            <div style="text-align: center;">PERSON</div>
          </td>
          <td style="border-left: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; width: 8.28%;">
            <div style="text-align: center;">10</div>
          </td>
          <td style="border-left: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; width: 59.25%; padding: 0px 0px 0px 5px;">
            <div>SHARED DISPOSITIVE POWER</div>
          </td>
        </tr>
        <tr>
          <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; width: 32.47%;">
            <div style="text-align: center;">WITH</div>
          </td>
          <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; width: 8.28%;">&#160;</td>
          <td style="border-bottom: 1px solid; border-left: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; width: 59.25%; padding: 0px 0px 0px 5px;">
            <div>2,500,000 (1)</div>
          </td>
        </tr>

    </table>
  </div>
  <div style="margin-bottom: 9pt;">
    <table cellspacing="0" cellpadding="0" id="z149c7cc4c46544a3a176f3c6c2e66ad3" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 5.69%;">
            <div style="text-align: center;">11</div>
          </td>
          <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 94.31%; padding: 0px 0px 0px 5px;">
            <div>AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>
              2,500,000 (1)</div>
          </td>
        </tr>
        <tr>
          <td style="border-bottom: 0px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 5.69%;">
            <div style="text-align: center;">12</div>
          </td>
          <td style="border-bottom: 0px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 94.31%; padding: 0px 0px 0px 5px;">
            <div>CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)<br>
              &#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 5.69%;">
            <div style="text-align: center;">13</div>
          </td>
          <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 94.31%; padding: 0px 0px 0px 5px;">
            <div>PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)<br>
              10.5%(2)</div>
          </td>
        </tr>
        <tr>
          <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 5.69%;">
            <div style="text-align: center;">14</div>
          </td>
          <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 94.31%; padding: 0px 0px 0px 5px;">
            <div>TYPE OF REPORTING PERSON (See Instructions)<br>
              OO</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z40ea46a0b2b64306b27cadf2c448027a">

      <tr>
        <td style="vertical-align: top; width: 5%;">
          <div style="text-align: justify;">(1)</div>
        </td>
        <td style="width: 92.4%; vertical-align: top;">
          <div style="text-align: justify;">Consists of 2,500,000 shares Common Stock held by Shareholder.&#160; Smiths Group plc may be deemed to have beneficial ownership over such shares since the Shareholder is a direct wholly-owned subsidiary of Smiths
            Group plc.</div>
        </td>
      </tr>
      <tr>
        <td style="vertical-align: top; width: 5%;">
          <div style="text-align: justify;">(2)</div>
        </td>
        <td style="width: 92.4%; vertical-align: top;">
          <div style="text-align: justify;">Based on the quotient obtained by dividing (a) the number of shares of Common Stock beneficially owned by Shareholder by (b) 21,239,119 shares of Common Stock outstanding as of October 31, 2021, as reported by
            the Issuer on November 5, 2021.</div>
        </td>
      </tr>

  </table>
  <div style="margin-bottom: 9pt;"><br>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div style="page-break-after: always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z7a7d898dfb024f92be8b3130a7fbcd96">

      <tr>
        <td style="vertical-align: top; width: 5%;">
          <div style="text-align: justify; font-weight: bold;">Item 1.</div>
        </td>
        <td style="width: 89.71%; vertical-align: top;">
          <div style="text-align: justify; font-weight: bold;">Security and Issuer.</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-top: 9pt; margin-bottom: 9pt;">The class of equity securities to which this Schedule 13D relates is the common stock, par value $0.10 per share (the &#8220;Common Stock&#8221;), of ICU Medical, Inc., a Delaware corporation
    (&#8220;ICU Medical&#8221;).&#160; The principal business address of ICU Medical is 951 Calle Amanecer, San Clemente, CA 92673.</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="za55adc28fd334dc19c143e376ce884b3">

      <tr>
        <td style="vertical-align: top; width: 5%;">
          <div style="text-align: justify; font-weight: bold;">Item 2.</div>
        </td>
        <td style="width: 89.71%; vertical-align: top;">
          <div style="text-align: justify; font-weight: bold;">Identity and Background.</div>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z383b1b17614d49068b8c3b142f0e8ec3">

      <tr>
        <td style="vertical-align: top; width: 5%;">
          <div>(a)</div>
        </td>
        <td style="width: 92.3%; vertical-align: top;">
          <div style="text-align: justify;">This statement is being filed by (i) Smiths Group plc, a public limited company incorporated in England and Wales and listed on the London Stock Exchange and (ii) Smiths Group International Holdings Limited, a
            private limited company incorporated in England and Wales (&#8220;Smiths Group&#8221; or &#8220;Shareholder&#8221;).</div>
        </td>
      </tr>
      <tr>
        <td style="vertical-align: top; width: 5%;">
          <div>(b)</div>
        </td>
        <td style="width: 92.3%; vertical-align: top;">
          <div style="text-align: justify;">The address for the principal business office of Smiths Group plc and the Shareholder is:</div>
        </td>
      </tr>
      <tr>
        <td style="vertical-align: top; width: 5%;">&#160;</td>
        <td style="width: 92.3%; vertical-align: top;">
          <div style="text-align: justify;">Smiths Group plc</div>
          <div style="text-align: justify;">4<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor, 11-12 St James&#8217;s Square</div>
          <div style="text-align: justify;">London, England, SW1Y 4LB</div>
        </td>
      </tr>
      <tr>
        <td style="vertical-align: top; width: 5%;">
          <div>(c)</div>
        </td>
        <td style="width: 92.3%; vertical-align: top;">
          <div style="text-align: justify;">Set forth on Schedule A hereto, which is incorporated herein by reference, is the name, business address and principal occupation or employment of each of (i) Smiths Group plc&#8217;s directors and executive officers
            and (ii) Shareholder&#8217;s directors and executive officers, (the &#8220;Scheduled Persons&#8221;).</div>
        </td>
      </tr>
      <tr>
        <td style="vertical-align: top; width: 5%;">
          <div>(e)</div>
        </td>
        <td style="width: 92.3%; vertical-align: top;">
          <div style="text-align: justify;">During the past five years, none of Smiths Group plc and Shareholder, and, to the knowledge of Smiths Group plc and Shareholder, none of the Scheduled Persons has, been (i) convicted in a criminal proceeding
            (excluding traffic violations and similar misdemeanors), or (ii) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final
            order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.</div>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z724a41203ad24ca79f883b59518fb28d">

      <tr>
        <td style="vertical-align: top; width: 5%;">
          <div style="text-align: justify; font-weight: bold;">Item 3.</div>
        </td>
        <td style="width: 89.13%; vertical-align: top;">
          <div style="text-align: justify; font-weight: bold;">Source and Amount of Funds or Other Consideration.</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-top: 9pt; margin-bottom: 9pt;">The shares of Common Stock disclosed herein were acquired pursuant to a Share Sale and Purchase Agreement (the &#8220;Purchase Agreement&#8221;), dated September 27, 2021, by and between
    Shareholder and ICU Medical.</div>
  <div style="text-align: justify; margin-bottom: 9pt;">The information set forth in or incorporated by reference into Items 4, 5 and 6 of this <font style="font-weight: bold;">Schedule 13D</font> is hereby incorporated by reference in its entirety into
    this Item 3.</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z716d78399fd24699861a34c22cc2dfca">

      <tr>
        <td style="vertical-align: top; width: 5%;">
          <div style="text-align: justify; font-weight: bold;">Item 4.</div>
        </td>
        <td style="width: 89.13%; vertical-align: top;">
          <div style="text-align: justify; font-weight: bold;">Purpose of Transaction.</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-top: 9pt; margin-bottom: 9pt;">Pursuant to the terms of the Purchase Agreement, ICU Medical purchased from Shareholder all of shares in the capital of Smiths Medical 2020 Limited, for an enterprise value of $2.7
    billion, plus an additional $0.1 billion contingent on the future share price performance of the enlarged ICU Medical business.&#160; As part of the consideration, Shareholder will receive 2,500,000 newly issued unregistered shares of Common Stock.&#160; In
    addition, Shareholder is entitled to receive a contingent amount of up to an addition $100 million in cash based on ICU Medical&#8217;s achievement of certain cumulative performance targets (i) on or prior to the third anniversary of Completion and (ii) on
    or prior to the fourth anniversary of Completion, respectively.</div>
  <div style="text-align: justify; margin-bottom: 9pt;">ICU Medical and Shareholder entered into a Shareholder Agreement (the &#8220;Shareholder Agreement&#8221;), dated January 6, 2021.&#160; The Shareholder Agreement imposes certain restrictions on Shareholder, including
    prohibiting certain transfers of the shares of Common Stock issued to Shareholder (i) to a Person who has filed or is part of a &#8220;group&#8221; (as defined in Section 13(d) of the Exchange Act) that has filed a Schedule 13D with the SEC in respect of Common
    Stock, unless Shareholder has provided ICU Medical with at least prior written notice of such intended transfer of at least one business day or (ii) to certain competitors of ICU Medical or certain other parties, as well as customary standstill
    limitations.</div>
  <div style="text-align: justify; margin-bottom: 9pt;">Under the Shareholder Agreement, Shareholder has the right to designate one individual for election to the board of directors of ICU Medical so long as Shareholder beneficially owns at least 5% of the
    total outstanding shares of Common Stock.&#160; Under the Shareholder Agreement, so long as (i) Shareholder beneficially owns at least 5% of the total outstanding shares of Common Stock, (ii) Shareholder has the right to designate one individual for
    election to the board of directors of ICU Medical under the Shareholders Agreement, or (iii) the director designated by Shareholder for appointment or election to the board of directors of ICU Medical serves on the board of directors as the
    Shareholder&#8217;s shareholder designee, Shareholder has agreed to vote its shares of Common Stock, subject to certain exceptions relating to significant corporate transactions, in accordance with the recommendation by the ICU Medical board of directors and
    in favor of persons nominated and recommended to serve as directors by the ICU Medical board of directors.&#160; Shareholder is entitled to demand and piggy-back registration rights.</div>
  <div style="text-align: justify; margin-bottom: 9pt;">The foregoing descriptions of the Purchase Agreement and the Shareholder Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of the Purchase
    Agreement and the Shareholder Agreement, which are filed as Exhibits 99.2 and 99.3 hereto, respectively, and are incorporated herein by reference.</div>
  <div style="text-align: justify; margin-bottom: 9pt;">Each of the entities listed in Item 2 (collectively, the &#8220;Filers&#8221;) expect that they will continuously monitor their investment in the Issuer.&#160; The Filers will, from time to time, review their
    investment in the shares of Common Stock and, to the extent permitted by the Shareholder Agreement, may determine to sell shares of Common Stock.</div>
  <div style="text-align: justify; margin-bottom: 9pt;">Except as otherwise described herein, the Filers do not presently have any plans or proposals which relate to or would result in any of the events, actions or conditions specified in paragraphs (a)
    through (j) of Item 4 of Schedule 13D.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div style="page-break-after: always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zcd240da422d0422e9cd56a7a1d26745c">

      <tr>
        <td style="vertical-align: top; width: 5%;">
          <div style="text-align: justify; font-weight: bold;">Item 5.</div>
        </td>
        <td style="width: 88.75%; vertical-align: top;">
          <div style="text-align: justify; font-weight: bold;">Interest in Securities of the Issuer.</div>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <div style="text-align: justify; margin-bottom: 9pt;">(a) - (b) Each of the Filers has beneficial ownership of 2,500,000 shares of Common Stock that the Issuer issued to the Shareholder pursuant to the Purchase Agreement and Shareholder Agreement, which
    represents 10.5% of the outstanding shares of Common Stock based upon 21,239,119 outstanding shares of Common Stock outstanding as of October 31, 2021, as reported by the Issuer on November 5, 2021 plus the 2,500,000 shares of Common Stock issued to
    the Shareholder pursuant to the Purchase Agreement and the Shareholder Agreement).&#160; Smiths Group plc may be deemed to have beneficial ownership over such 2,500,000 shares of Common Stock since the Shareholder is a direct wholly-owned subsidiary of
    Smiths Group plc.&#160; The Filers share power to vote or to direct the vote of and power to dispose or to direct the disposition of such 2,500,000 shares of Common Stock.</div>
  <div style="text-align: justify; margin-bottom: 9pt;">(c) The Filers acquired the 2,500,000 shares of Common Stock pursuant to the Purchase Agreement and the Shareholder Agreement.&#160; Except for such acquisition, during the last sixty days, none of the
    Filers nor, to their knowledge, any of their respective directors or executive officers, has purchased or sold any shares of Common Stock.</div>
  <div style="text-align: justify; margin-bottom: 9pt;">(d) No person is known to the Reporting Person to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, any securities covered by this <font style="font-weight: bold;">Schedule 13D</font>.</div>
  <div style="text-align: justify; margin-bottom: 9pt;">(e) Not Applicable.</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zf7d334a0960b485ab99088081d3b905d">

      <tr>
        <td style="vertical-align: top; width: 5%;">
          <div style="text-align: justify; font-weight: bold;">Item 6.</div>
        </td>
        <td style="width: 89.42%; vertical-align: top;">
          <div style="text-align: justify; font-weight: bold;">Contracts, Arrangements, Understandings or Relationships with respect to Securities of the Issuer.</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-top: 9pt; margin-bottom: 9pt;">Other than as described in Items 3, 4 and 5, which disclosure is incorporated into this Item 6 by reference, to Smiths Group plc&#8217;s and the Shareholder&#8217;s knowledge, there are no
    contracts, arrangements, understandings or relationships (legal or otherwise) among the persons named in Item 2 and between such persons and any person with respect to any securities of ICU Medical.</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z1e63a8c1e33a480f89ccf58140b7f6ba">

      <tr>
        <td style="vertical-align: top; width: 5%;">
          <div style="text-align: justify; font-weight: bold;">Item 7.</div>
        </td>
        <td style="width: 89.42%; vertical-align: top;">
          <div style="text-align: justify; font-weight: bold;">Material to be Filed as Exhibits.</div>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z810f7a508b5e46c19eb25e86e91e667e">

      <tr>
        <td style="border-bottom: 1px solid; vertical-align: top; width: 5%;">
          <div style="text-align: justify; font-weight: bold;">Exhibit<br>
            No.</div>
        </td>
        <td style="vertical-align: top; width: 1%;">&#160;</td>
        <td style="border-bottom: 1px solid; vertical-align: bottom; width: 86.54%;">
          <div style="text-align: justify; font-weight: bold;">Description</div>
        </td>
      </tr>
      <tr>
        <td style="vertical-align: top; width: 5%;">
          <div style="text-align: justify;">99.1</div>
        </td>
        <td style="vertical-align: top; width: 1%;">&#160;</td>
        <td style="width: 86.54%; vertical-align: top;">
          <div style="text-align: justify;">Joint Filing Agreement, dated as of January 12, 2022, by and between Smiths Group plc and Smiths Group.</div>
        </td>
      </tr>
      <tr>
        <td style="vertical-align: top; width: 5%;">
          <div style="text-align: justify;">99.2</div>
        </td>
        <td style="vertical-align: top; width: 1%;">&#160;</td>
        <td style="width: 86.54%; vertical-align: top;">
          <div style="text-align: justify;">Share Sale and Purchase Agreement, dated September 8, 2021, by and between Smiths Group and ICU Medical (incorporated by reference to Exhibit 2.1 to ICU Medical&#8217;s Form 8-K filed on September 8, 2021).</div>
        </td>
      </tr>
      <tr>
        <td style="vertical-align: top; width: 5%;">
          <div style="text-align: justify;">99.3</div>
        </td>
        <td style="vertical-align: top; width: 1%;">&#160;</td>
        <td style="width: 86.54%; vertical-align: top;">
          <div style="text-align: justify;">Shareholders Agreement, by and between Smiths Group and ICU Medical (incorporated by reference to Exhibit 10.1 to ICU Medical&#8217;s Form 8-K filed on January 7, 2022).</div>
        </td>
      </tr>
      <tr>
        <td style="vertical-align: top; width: 5%;" rowspan="1">99.4 <br>
        </td>
        <td style="vertical-align: top; width: 1%;" rowspan="1">&#160;</td>
        <td style="width: 86.54%; vertical-align: top;" rowspan="1">Smiths Group plc Power of Attorney<br>
        </td>
      </tr>

  </table>
  <div style="margin-bottom: 9pt;"><br>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: center; margin-bottom: 9pt; font-weight: bold;">SIGNATURE</div>
  <div style="text-align: justify; margin-bottom: 9pt;">After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.</div>
  <div style="text-align: justify; margin-bottom: 9pt;">Date: January 12, 2022</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z18c7d9e9be6946288479a5eb9a55dafc">

      <tr>
        <td colspan="2" style="width: 50.25%; vertical-align: top;">
          <div style="text-align: justify;">Smiths Group plc</div>
        </td>
        <td style="vertical-align: top; width: 70%;">&#160;</td>
      </tr>
      <tr>
        <td style="vertical-align: top; width: 5%;">
          <div style="text-align: justify;">By:</div>
        </td>
        <td style="border-bottom: 1px solid; vertical-align: top; width: 20%;">
          <div style="text-align: justify;">/s/ Matthew John Whyte</div>
        </td>
        <td style="vertical-align: top; width: 70%;">&#160;</td>
      </tr>
      <tr>
        <td style="vertical-align: top; width: 5%;">
          <div style="text-align: justify;">Name:</div>
        </td>
        <td style="vertical-align: top; width: 20%;">
          <div style="text-align: justify;">Matthew John Whyte</div>
        </td>
        <td style="vertical-align: top; width: 70%;">&#160;</td>
      </tr>
      <tr>
        <td style="vertical-align: top; width: 5%;">&#160;</td>
        <td style="vertical-align: top; width: 20%;">&#160;</td>
        <td style="vertical-align: top; width: 70%;">&#160;</td>
      </tr>
      <tr>
        <td style="vertical-align: top; width: 5%;">&#160;</td>
        <td style="vertical-align: top; width: 20%;">&#160;</td>
        <td style="vertical-align: top; width: 70%;">&#160;</td>
      </tr>
      <tr>
        <td colspan="2" style="width: 50.25%; vertical-align: top;">
          <div>Smiths Group International Holdings Limited</div>
        </td>
        <td style="vertical-align: top; width: 70%;">&#160;</td>
      </tr>
      <tr>
        <td style="vertical-align: top; width: 5%;">
          <div style="text-align: justify;">By:</div>
        </td>
        <td style="border-bottom: 1px solid; vertical-align: top; width: 20%;">
          <div style="text-align: justify;">/s/ Matthew John Whyte</div>
        </td>
        <td style="vertical-align: top; width: 70%;">&#160;</td>
      </tr>
      <tr>
        <td style="vertical-align: top; width: 5%;">
          <div style="text-align: justify;">Name:</div>
        </td>
        <td style="vertical-align: top; width: 20%;">
          <div style="text-align: justify;">Matthew John Whyte</div>
        </td>
        <td style="vertical-align: top; width: 70%;">&#160;</td>
      </tr>

  </table>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: center; margin-bottom: 6pt; font-weight: bold;">SCHEDULE A</div>
  <div style="text-align: center; margin-bottom: 6pt; font-weight: bold;">Name, business address, present principal occupation or employment and place of citizenship of the directors and executive officers of Smiths Group plc</div>
  <div style="text-align: justify; margin-bottom: 9pt;">The business address of each director and executive officer is c/o Smiths Group plc, 4<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor, 11-12 St James&#8217;s Square, London, England, SW1Y 4LB.&#160; Unless otherwise indicated, each
    director and executive officer is a citizen of the United Kingdom.</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zc470dd10074b4c50a510e7a0e96e2833">

      <tr>
        <td style="width: 40.38%; vertical-align: top;">
          <div style="font-weight: bold;">NAME AND POSITION</div>
        </td>
        <td style="width: 59.62%; vertical-align: top;">
          <div style="font-weight: bold;">PRESENT PRINCIPAL OCCUPATION OR EMPLOYMENT AND CITIZENSHIP</div>
        </td>
      </tr>
      <tr>
        <td style="width: 40.38%; vertical-align: top;">
          <div><font style="font-weight: bold;">Sir George Buckley</font><br>
            Chairman of the Board, Director</div>
        </td>
        <td style="width: 59.62%; vertical-align: top;">
          <div>Chairman of the Board, Smiths Group plc and company director<br>
            Sir George Buckley is a citizen of the United States and the United Kingdom</div>
        </td>
      </tr>
      <tr>
        <td style="width: 40.38%; vertical-align: top;">
          <div><font style="font-weight: bold;">Pam Cheng</font><br>
            Non-Executive Director</div>
        </td>
        <td style="width: 59.62%; vertical-align: top;">
          <div>Director Smiths Group plc and Executive Vice-President, Operations and Information Technology for AstraZeneca plc<br>
            Ms Cheng is a citizen of the United States</div>
        </td>
      </tr>
      <tr>
        <td style="width: 40.38%; vertical-align: top;">
          <div><font style="font-weight: bold;">Ann Dame Dowling</font><br>
            Non-Executive Director</div>
        </td>
        <td style="width: 59.62%; vertical-align: top;">
          <div>Director Smiths Group plc and Deputy Vice Chancellor and an Emeritus Professor of Mechanical Engineering at the University of Cambridge<br>
            Dame Ann Dowling is a citizen of the United Kingdom</div>
        </td>
      </tr>
      <tr>
        <td style="width: 40.38%; vertical-align: top;">
          <div><font style="font-weight: bold;">Tanya Fratto</font><br>
            Non-Executive Director</div>
        </td>
        <td style="width: 59.62%; vertical-align: top;">
          <div>Director Smiths Group plc and company director<br>
            Ms Fratto is a citizen of the United States</div>
        </td>
      </tr>
      <tr>
        <td style="width: 40.38%; vertical-align: top;">
          <div><font style="font-weight: bold;">Karin Hoeing-Cosentino</font><br>
            Non-Executive Director</div>
        </td>
        <td style="width: 59.62%; vertical-align: top;">
          <div>Director Smiths Group plc and Group Human Resources Director, BAE Systems plc<br>
            Ms Hoeing-Consentino is a citizen of Germany</div>
        </td>
      </tr>
      <tr>
        <td style="width: 40.38%; vertical-align: top;">
          <div><font style="font-weight: bold;">Paul Keel</font><br>
            Chief Executive Officer, Director</div>
        </td>
        <td style="width: 59.62%; vertical-align: top;">
          <div>Director, Chief Executive Officer, Smiths Group plc<br>
            Mr Keel is a citizen of the United States</div>
        </td>
      </tr>
      <tr>
        <td style="width: 40.38%; vertical-align: top;">
          <div><font style="font-weight: bold;">William Claire Seeger JR</font><br>
            Senior Independent Director</div>
        </td>
        <td style="width: 59.62%; vertical-align: top;">
          <div>Director Smiths Group plc and company director<br>
            Mr Seeger is a citizen of the United States</div>
        </td>
      </tr>
      <tr>
        <td style="width: 40.38%; vertical-align: top;">
          <div><font style="font-weight: bold;">Mark Seligman</font><br>
            Non-Executive Director</div>
        </td>
        <td style="width: 59.62%; vertical-align: top;">
          <div>Director Smiths Group plc and company director<br>
            Mr Seligman is a citizen of the United Kingdom</div>
        </td>
      </tr>
      <tr>
        <td style="width: 40.38%; vertical-align: top;">
          <div><font style="font-weight: bold;">John Shipsey</font><br>
            Chief Executive Officer, Director</div>
        </td>
        <td style="width: 59.62%; vertical-align: top;">
          <div>Director, Chief Financial Officer, Smiths Group plc<br>
            Mr Shipsey is a citizen of the United Kingdom and Ireland</div>
        </td>
      </tr>
      <tr>
        <td style="width: 40.38%; vertical-align: top;">
          <div><font style="font-weight: bold;">Noel Tata</font><br>
            Non-Executive Director</div>
        </td>
        <td style="width: 59.62%; vertical-align: top;">
          <div>Director Smiths Group plc and company director<br>
            Mr Tata is a citizen of Ireland</div>
        </td>
      </tr>
      <tr>
        <td style="width: 40.38%; vertical-align: top;">
          <div><font style="font-weight: bold;">Roland Carter</font><br>
            President, Smiths Detection and Asia Pacific</div>
        </td>
        <td style="width: 59.62%; vertical-align: top;">
          <div>President, Smiths Detection and Asia Pacific<br>
            Mr Carter is a citizen of the United Kingdom</div>
        </td>
      </tr>
      <tr>
        <td style="width: 40.38%; vertical-align: top;">
          <div><font style="font-weight: bold;">Julian Fagge</font><br>
            President, Smiths Interconnect</div>
        </td>
        <td style="width: 59.62%; vertical-align: top;">
          <div>President, Smiths Interconnect<br>
            Mr Fagge is a citizen of the United Kingdom</div>
        </td>
      </tr>
      <tr>
        <td style="width: 40.38%; vertical-align: top;">
          <div><font style="font-weight: bold;">Sheena Mackay</font><br>
            Group HR Director</div>
        </td>
        <td style="width: 59.62%; vertical-align: top;">
          <div>Group HR Director, Smiths Group plc<br>
            Ms Mackay is a citizen of the United Kingdom</div>
        </td>
      </tr>
      <tr>
        <td style="width: 40.38%; vertical-align: top;">
          <div><font style="font-weight: bold;">Pat McCaffrey</font><br>
            President, Flex-Tek</div>
        </td>
        <td style="width: 59.62%; vertical-align: top;">
          <div>President, Flex-Tek<br>
            Mr McCaffrey is a citizen of the United States</div>
        </td>
      </tr>
      <tr>
        <td style="width: 40.38%; vertical-align: top;">
          <div style="font-weight: bold;">John Ostergren Chief Sustainability Officer</div>
        </td>
        <td style="width: 59.62%; vertical-align: top;">
          <div>Chief Sustainability Officer, Smiths Group plc</div>
          <div>Mr Ostergren is a citizen of the United States</div>
        </td>
      </tr>
      <tr>
        <td style="width: 40.38%; vertical-align: top;">
          <div><font style="font-weight: bold;">Melanie Rowlands</font><br>
            Group General Counsel</div>
        </td>
        <td style="width: 59.62%; vertical-align: top;">
          <div>Group General Counsel, Smiths Group plc<br>
            Ms Rowlands is a citizen of the United Kingdom</div>
        </td>
      </tr>
      <tr>
        <td style="width: 40.38%; vertical-align: top;">
          <div><font style="font-weight: bold;">Sir Kevin Tebbit</font><br>
            Senior Vice President, Corporate Affairs</div>
        </td>
        <td style="width: 59.62%; vertical-align: top;">
          <div>Senior Vice President, Corporate Affairs, Smiths Group plc<br>
            Sir Kevin Tebbit is a citizen of the United Kingdom</div>
        </td>
      </tr>
      <tr>
        <td style="width: 40.38%; vertical-align: top;">
          <div><font style="font-weight: bold;">Tony Tielen</font><br>
            Group Operational Excellence Director</div>
        </td>
        <td style="width: 59.62%; vertical-align: top;">
          <div>Group Operational Excellence Director, Smiths Group plc<br>
            Mr Tielen is a citizen of the Netherlands</div>
        </td>
      </tr>
      <tr>
        <td style="width: 40.38%; vertical-align: top;">
          <div><font style="font-weight: bold;">Jean Vernet</font><br>
            President, John Crane</div>
        </td>
        <td style="width: 59.62%; vertical-align: top;">
          <div>President, John Crane<br>
            Mr Vernet is a citizen of France</div>
        </td>
      </tr>

  </table>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div style="page-break-after:always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: center; margin-bottom: 9pt; font-weight: bold;">Name, business address, present principal occupation or employment and place of citizenship of the directors and executive officers of Smiths Group International Holdings Limited</div>
  <div style="text-align: justify; margin-bottom: 9pt;">The business address of each director and executive officer is c/o Smiths Group plc, 4<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor, 11-12 St James&#8217;s Square, London, England, SW1Y 4LB.&#160; Unless otherwise indicated, each
    director and executive officer is a citizen of the United Kingdom.</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z399d13b25e1f4c579a199901289a134d">

      <tr>
        <td style="width: 41.71%; vertical-align: top;">
          <div style="font-weight: bold;">NAME AND POSITION</div>
        </td>
        <td style="width: 58.29%; vertical-align: top;">
          <div style="font-weight: bold;">PRESENT PRINCIPAL OCCUPATION OR EMPLOYMENT AND CITIZENSHIP</div>
        </td>
      </tr>
      <tr>
        <td style="width: 41.71%; vertical-align: top;">
          <div><font style="font-weight: bold;">Sheena Mackay</font><br>
            Director</div>
        </td>
        <td style="width: 58.29%; vertical-align: top;">
          <div>Director and Group HR Director, Smiths Group plc<br>
            Ms Mackay is a citizen of the United Kingdom</div>
        </td>
      </tr>
      <tr>
        <td style="width: 41.71%; vertical-align: top;">
          <div><font style="font-weight: bold;">Julian Fagge</font><br>
            Director</div>
        </td>
        <td style="width: 58.29%; vertical-align: top;">
          <div>Director and President, Smiths Interconnect<br>
            Mr Fagge is a citizen of the United Kingdom</div>
        </td>
      </tr>
      <tr>
        <td style="width: 41.71%; vertical-align: top;">
          <div><font style="font-weight: bold;">John Shipsey</font><br>
            Director</div>
        </td>
        <td style="width: 58.29%; vertical-align: top;">
          <div>Director and Director, Chief Financial Officer, Smiths Group plc<br>
            Mr Shipsey is a citizen of the United Kingdom and Ireland</div>
        </td>
      </tr>

  </table>
  <div style="margin-bottom: 9pt;"><br>
  </div>
  <div style="margin-bottom: 9pt;"><br>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1 CHARTER
<SEQUENCE>2
<FILENAME>joint_filing_agreement.htm
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: White & Case
         Document created using EDGARfilings PROfile 8.0.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; margin-bottom: 9pt; font-weight: bold;">Exhibit 99.1</div>
    <div style="text-align: center; margin-bottom: 9pt; font-weight: bold;">Joint Filing Agreement Pursuant to Rule 13d-1</div>
    <div style="text-align: justify; margin-bottom: 9pt;">This agreement is made pursuant to Rule 13d-l(k)(1) under the Securities and Exchange Act of 1934, as amended (the &#8220;Act&#8221;), by and among
      the parties listed below, each referenced to herein as a &#8220;Joint Filer.&#8221; The Joint Filers agree that a statement of beneficial ownership as required by Sections 13(g) or 13(d) of the Act and the Rules thereunder may be filed on each of their behalf on
      Schedule 13G or Schedule 13D, as appropriate, and that said joint filing may thereafter be amended by further joint filings. The Joint Filers state that they each satisfy the requirements for making a joint filing under Rule 13d-1.</div>
    <div style="text-align: justify; margin-bottom: 18pt;">Dated: January 12, 2022</div>
    <table cellspacing="0" cellpadding="0" id="z3c8b5c4359c04ed092ffad75213cf30b" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54.16%; vertical-align: top;" colspan="2">
            <div style="text-align: justify; font-weight: bold;">SMITHS GROUP PLC</div>
          </td>
          <td style="vertical-align: top; width: 80%;">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 5%;">
            <div style="text-align: justify;">By:</div>
          </td>
          <td style="border-bottom: 1px solid; vertical-align: top; width: 25%;">
            <div style="text-align: justify;">/s/ Matthew John Whyte</div>
          </td>
          <td style="vertical-align: top; width: 80%;">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 5%;">
            <div style="text-align: justify;">Name:</div>
          </td>
          <td style="vertical-align: top; width: 25%;">
            <div style="text-align: justify;">Matthew John Whyte</div>
          </td>
          <td style="vertical-align: top; width: 80%;">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 5%;">
            <div style="text-align: justify;">Title:</div>
          </td>
          <td style="vertical-align: top; width: 25%;">
            <div style="text-align: justify;">Attorney-in-Fact</div>
          </td>
          <td style="vertical-align: top; width: 80%;">&#160;</td>
        </tr>

    </table>
    <div style="margin-bottom: 9pt;"><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z9fd47b411f864149bb2412dd75d59d11" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 65.19%; vertical-align: top;" colspan="2">
            <div style="text-align: justify; font-weight: bold;">SMITHS GROUP INTERNATIONAL HOLDINGS LIMITED</div>
          </td>
          <td style="vertical-align: top; width: 80%;">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 5%;">
            <div style="text-align: justify;">By:</div>
          </td>
          <td style="border-bottom: 1px solid; vertical-align: top; width: 25%;">
            <div style="text-align: justify;">/s/ Matthew John Whyte</div>
          </td>
          <td style="vertical-align: top; width: 80%;">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 5%;">
            <div style="text-align: justify;">Name:</div>
          </td>
          <td style="vertical-align: top; width: 25%;">
            <div style="text-align: justify;">Matthew John Whyte</div>
          </td>
          <td style="vertical-align: top; width: 80%;">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; width: 5%;">
            <div style="text-align: justify;">Title:</div>
          </td>
          <td style="vertical-align: top; width: 25%;">
            <div style="text-align: justify;">Attorney-in-Fact</div>
          </td>
          <td style="vertical-align: top; width: 80%;">&#160;</td>
        </tr>

    </table>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4 ACQ AGREEMNT
<SEQUENCE>3
<FILENAME>power_of_attorney.htm
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: White & Case
         Document created using EDGARfilings PROfile 8.0.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;">POWER OF ATTORNEY</div>
    <div style="text-align: justify; margin-bottom: 12pt;">The undersigned constitutes and appoints John Shipsey and Matthew Whyte or any of them acting singly, as the undersigned&#8217;s true and lawful attorneys-in-fact and agents, with full power of
      substitution and resubstitution, for the undersigned and in the undersigned&#8217;s name, place and stead, to:</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z2cda7cf265a040bb816a6d0542c3bf42">

        <tr>
          <td style="width: 10.97%; vertical-align: top;">
            <div style="text-align: justify;">1.</div>
          </td>
          <td style="width: 89.03%; vertical-align: top;">
            <div style="text-align: justify;">prepare, sign, and submit to the Securities and Exchange Commission (the &#8220;SEC&#8221;) on its Electronic Data Gathering, Analysis, and Retrieval (&#8220;EDGAR&#8221;) Filer Management website a Form ID application, including any
              amendments and exhibits thereto, and any other related documents as may be necessary or appropriate, to obtain from the SEC access codes to permit filing on the SEC&#8217;s EDGAR system, granting unto said attorneys-in-fact and agents, and each of
              them, full power and authority to do and perform each act and thing requisite and necessary to be done as required by any rule or regulation of the SEC and the EDGAR Filer Manual as fully and to all intents and purposes as the undersigned
              might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, and each of them, may lawfully do or cause to be done by virtue hereof; and</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10.97%; vertical-align: top;">&#160;</td>
          <td style="width: 89.03%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 10.97%; vertical-align: top;">
            <div style="text-align: justify;">2.</div>
          </td>
          <td style="width: 89.03%; vertical-align: top;">
            <div style="text-align: justify;">sign any and all SEC statements of beneficial ownership of securities of Smiths Group Plc. (the &#8220;Company&#8221;) on Schedule 13D as required under Section 13 and Forms 3, 4 and 5 as required under Section 16(a) of
              the Securities Exchange Act of 1934, as amended, and any amendments thereto, and to file the same with all exhibits thereto, and other documents in connection therewith, with the SEC, the Company and any stock exchange on which any of the
              Company&#8217;s securities are listed, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each act and thing requisite and necessary to be done under said Section 13 and Section 16(a), as
              fully and to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, and each of them, may lawfully do or cause to be done by virtue hereof.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10.97%; vertical-align: top;">&#160;</td>
          <td style="width: 89.03%; vertical-align: top;">&#160;</td>
        </tr>

    </table>
    <div style="text-align: justify; margin-bottom: 12pt;">A copy of this power of attorney shall be filed with the SEC.&#160; The authorization set forth above shall continue in full force and effect until the undersigned revokes such authorization by written
      instructions to the attorneys-in-fact.</div>
    <div style="text-align: justify; margin-bottom: 12pt;">The authority granted hereby shall in no event be deemed to impose or create any duty on behalf of the attorneys-in-fact with respect to the undersigned&#8217;s obligations to file a Form ID, Schedule
      13Ds and Forms 3, 4 and 5 with the SEC.</div>
    <div style="text-align: justify; margin-bottom: 12pt;">Dated: January 10, 2022</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zd009f6a7f89f4d76beb96f32ec021fd1">

        <tr>
          <td style="width: 49.76%; vertical-align: top;">&#160;</td>
          <td colspan="4" style="width: 50.24%; vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">SMITHS GROUP PLC.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.76%; vertical-align: top;">&#160;</td>
          <td colspan="4" style="width: 50.24%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49.76%; vertical-align: top;">&#160;</td>
          <td colspan="4" style="width: 50.24%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49.76%; vertical-align: top;">&#160;</td>
          <td style="vertical-align: top; width: 3%;">
            <div style="text-align: justify;">By:</div>
          </td>
          <td colspan="2" style="border-bottom: 1px solid #000000; vertical-align: top; width: 35.14%;">
            <div style="text-align: justify;">/s/ John Shipsey</div>
          </td>
          <td style="vertical-align: top; width: 30%;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49.76%; vertical-align: top;">&#160;</td>
          <td style="vertical-align: top; width: 3%;">&#160;</td>
          <td style="vertical-align: top; width: 3%;">
            <div style="text-align: justify;">Name:</div>
          </td>
          <td style="vertical-align: top; width: 15%;">
            <div style="text-align: justify;">John Shipsey</div>
          </td>
          <td style="vertical-align: top; width: 30%;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49.76%; vertical-align: top;">&#160;</td>
          <td style="vertical-align: top; width: 3%;">&#160;</td>
          <td style="vertical-align: top; width: 3%;">
            <div style="text-align: justify;">Title:</div>
          </td>
          <td style="vertical-align: top; width: 15%;">
            <div style="text-align: justify;">Director</div>
          </td>
          <td style="vertical-align: top; width: 30%;">&#160;</td>
        </tr>

    </table>
    <div style="margin-bottom: 12pt;"><br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
